OCUMENSION THERAPEUTICS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.89 HKD | +0.44% |
|
+1.92% | +3.14% |
| 04-15 | Ocumension Therapeutics Completes Phase III Trials for Postoperative Inflammation Drug | MT |
| 04-15 | Ocumension Therapeutics Announces Phase III Clinical Trial of OT-502 in China | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OCUMENSION THERAPEUTICS | Other Pharmaceuticals | +0.44% | +1.92% | +3.14% | -1.57% | - | 609M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- 1477 Stock
- Charts Ocumension Therapeutics
- Comparison Chart
